According to Assertio Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.26 B. a decrease over its 2022 earnings that were of $39.01 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$0.26 B | -743.61% |
2022 | $39.01 M | 305.35% |
2021 | $9.62 M | -132.53% |
2020 | -$29.59 M | -81.97% |
2019 | -$0.17 B | -253.57% |
2018 | $0.10 B | -451.81% |
2017 | -$30.38 M | -258.05% |
2016 | $19.21 M | -138.59% |
2015 | -$49.81 M | -121.01% |
2014 | $0.23 B | 2275.01% |
2013 | $9.98 M | -133.45% |
2012 | -$29.84 M | -141.87% |
2011 | $71.25 M | 1496.17% |
2010 | $4.46 M | -121.23% |
2009 | -$21.03 M | 22.98% |
2008 | -$17.1 M | -135.96% |
2007 | $47.53 M | |
2003 | -$29.4 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -26.60% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | -92.45% | ๐บ๐ธ USA |